William Schaffner, MD, medical director of the National Foundation for Infectious Diseases (NFID), has been named the 2017 National Vaccine Program Office (NVPO) UpShot Award winner for excellence in vaccine communication.
NVPO recognized Schaffner for his tireless commitment to harnessing the power of collaboration and innovation to provide clear, actionable, evidence-based information about vaccines to healthcare professionals, the media and parents across the nation.
“Congratulations to Dr. Schaffner for receiving this well-deserved honor,” said Marla Dalton, CAE, NFID executive director and CEO. “During these times of uncertainty, with misinformation being widely shared across the internet and social media, the importance of being a sustained and passionate communicator to both healthcare professionals and the public becomes more evident than ever. Dr. Schaffner is consistently the voice of reason in ongoing public debates regarding vaccine skepticism and remains dedicated to promoting sound science on the importance and safety of vaccines.”
As NFID medical director, Schaffner works tirelessly to advance the NFID mission of educating healthcare professionals and the public about the causes, prevention and treatment of infectious diseases across the lifespan. As a professor of preventive medicine and infectious diseases at the Vanderbilt University School of Medicine, he has mentored generations of vaccine advocates who now share his passion for communicating about important public health issues, with a focus on vaccines.
Schaffner is also a “go to” source for health and science reporters for both professional and consumer outlets. He is frequently called upon to provide scientific advice and perspective about emerging infectious disease issues in language that speaks directly to those who need the information most. Reporters routinely describe Schaffner as one of the top medical communicators. Among his many skills is the consistent ability to filter through seemingly disparate needs and views to find common ground among stakeholders.
Source: National Foundation for Infectious Diseases (NFID)
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies